In regards to the glucose and insulin, as a component of the ‘Metabolic-Syndrome’ profile, some data suggest that elevated serum levels of these markers may be considered as predictors for breast cancer [33,38,57], however, there is not enough evidence [37,54,55]. The gene discussed is INS; the disease is breast cancer.